Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation

被引:26
|
作者
Riches, Z. [1 ]
Bloomer, J. [2 ]
Patel, A. [2 ]
Nolan, A. [2 ]
Coughtrie, M. [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland
[2] GlaxoSmithKline Inc, Ware, Herts, England
基金
英国生物技术与生命科学研究理事会;
关键词
Sulfation; glucuronidation; hepatocytes; cryopreservation; paracetamol; inhibition; UDP-GLUCURONOSYLTRANSFERASE ISOFORMS; HUMAN LIVER-MICROSOMES; ACETAMINOPHEN GLUCURONIDATION; INTERINDIVIDUAL VARIABILITY; PARACETAMOL METABOLISM; PHASE-I; PHARMACOKINETICS; HEPATOTOXICITY; IDENTIFICATION; PREDICTION;
D O I
10.1080/00498250902763440
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cultured cryopreserved human hepatocytes are extensively used as a model system for studying drug metabolism, although they remain poorly characterized in respect of the major conjugation reactions glucuronidation and sulfation. Using paracetamol (acetaminophen), we assessed eleven samples of cryopreserved human hepatocytes for their suitability to investigate the simultaneous glucuronidation and sulfation of xenobiotics and evaluated inhibitors of conjugation. Kinetic characterization showed broadly similar values for paracetamol conjugation by hepatocytes (as reported in the literature for in vitro systems), with Km values of approximately 6 mM and 0.3 mM for glucuronidation and sulfation, respectively. Substantial interindividual differences were observed. The hepatocytes demonstrated a strong dose-dependent switch from a preponderance of sulfation at low concentrations of paracetamol to glucuronidation at higher doses, consistent with routes of clearance in vivo. A number of drugs, some of which such as probenecid and sulfinpyrazone are known to interact with paracetamol in vivo, were demonstrated to inhibit the sulfation and/or glucuronidation of paracetamol in hepatocytes, demonstrating the potential application of this model system for studying drug-drug interactions involving conjugation.
引用
收藏
页码:374 / 381
页数:8
相关论文
共 19 条
  • [1] SULFATION AND GLUCURONIDATION OF ACETAMINOPHEN BY HUMAN HEPATOCYTES CULTURED ON MATRIGEL AND TYPE-1 COLLAGEN REPRODUCES CONJUGATION IN-VIVO
    KANE, RE
    LI, AP
    KAMINSKI, DR
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (03) : 303 - 307
  • [2] Cryopreserved HUMAN Hepatocytes as A MODEL for the EVALUATION of TOXICITY and Drug-Drug Interactions
    Richert, Lysiane
    Baze, Audrey
    Desbans, Coraline
    Parmentier, Celine
    Heyd, Bruno
    Mantion, Georges
    Bachellier, Philippe
    Weber, Jean-Christophe
    Zacharias, Thomas
    Simon, Sandrine
    Ungell, Anna-Lena
    Annaert, Pieter
    Alexandre, Eliane
    DRUG METABOLISM REVIEWS, 2010, 42 : 76 - 76
  • [3] A Novel In Vitro Experimental System for the Evaluation of Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Cryopreserved Human Hepatocytes)
    Li, Albert P.
    Ho, Ming-Chih David
    Amaral, Kirsten
    Loretz, Carol
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (11) : 1608 - 1616
  • [4] Use of selective substrates and inhibitors to rapidly characterise batches of cryopreserved primary human hepatocytes for assessment of active uptake liability in drug discovery and development
    Golding, Melanie
    Light, Oliver
    Williamson, Beth
    Menochet, Karelle
    XENOBIOTICA, 2022, 52 (08) : 868 - 877
  • [5] Determination of Time-Dependent Inactivation of CYP3A4 in Cryopreserved Human Hepatocytes and Assessment of Human Drug-Drug Interactions
    Chen, Yuan
    Liu, Liling
    Monshouwer, Mario
    Fretland, Adrian J.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (11) : 2085 - 2092
  • [6] Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction
    Hengstler, JG
    Utesch, D
    Steinberg, P
    Platt, K
    Diener, B
    Ringel, M
    Swales, N
    Fischer, T
    Biefang, K
    Gerl, M
    Böttger, T
    Oesch, F
    DRUG METABOLISM REVIEWS, 2000, 32 (01) : 81 - 118
  • [7] Human HepaRG Hepatocytes, an Alternative In Vitro Model for Assessment of Drug Metabolism Induction
    Li, Ruoya
    Antherieu, Sebastien
    Turpeinen, Miia
    Camus, Sandrine
    Josse, Rozenn
    Uusitalo, Jouko
    Christiane, Guguen-Guillouzo
    Guillouzo, Andre
    Tolonen, Ari
    Rougier, Nathalie
    Chesne, Christophe
    DRUG METABOLISM REVIEWS, 2009, 41 : 57 - 57
  • [8] Evaluating variations in bilirubin glucuronidation activity by protease inhibitors in canine and human primary hepatocytes cultured in a 3D culture system
    Omori, Hisayoshi
    Chikamoto, Junko
    Nagahara, Megumi
    Hirata, Maki
    Otoi, Takeshige
    TOXICOLOGY IN VITRO, 2023, 93
  • [9] Evaluation of adverse drug properties with cryopreserved human hepatocytes and the integrated discrete multiple organ co-culture (IdMOC™) system
    Li A.P.
    Toxicological Research, 2015, 31 (2) : 137 - 149
  • [10] Characterization of proliferating human hepatocytes as a model system for drug interaction studies and toxicity screenings
    Noerenberg, A.
    Tolosa, L.
    Lechon, M. Gomez
    Runge, N.
    Johannssen, T.
    Lopez, S.
    Guzman, C.
    Castell, J.
    Donato, M.
    Jover, R.
    TOXICOLOGY LETTERS, 2016, 258 : S200 - S200